Page 3 - Tmbr News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Tmbr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Tmbr Today - Breaking & Trending Today
Canadian Trade Minister Mary Ng met U.S. Trade Representative Katherine Tai on Tuesday and the two discussed working together to address "shared challenges" regarding Mexico's energy and mining sector reforms, according to a statement from the Canadian ministry. ....
Timber Pharmaceuticals (NYSE:TMBR – Get Rating) and Seres Therapeutics (NASDAQ:MCRB – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk. Profitability This table compares Timber Pharmaceuticals and Seres Therapeutics’ […] ....
Timber Pharmaceuticals, Inc. (NYSE:TMBR – Get Rating) – Equities research analysts at HC Wainwright raised their Q1 2023 earnings estimates for shares of Timber Pharmaceuticals in a note issued to investors on Monday, April 10th. HC Wainwright analyst R. Selvaraju now expects that the company will post earnings of ($1.17) per share for the quarter, […] ....
HC Wainwright restated their buy rating on shares of Timber Pharmaceuticals (NYSE:TMBR – Get Rating) in a research note issued to investors on Monday morning, Benzinga reports. HC Wainwright currently has a $11.00 target price on the stock. HC Wainwright also issued estimates for Timber Pharmaceuticals’ Q1 2023 earnings at ($1.17) EPS, Q2 2023 earnings […] ....
Timber Pharmaceuticals (NYSE:TMBR – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research note issued on Monday, Benzinga reports. They currently have a $11.00 price objective on the stock. HC Wainwright also issued estimates for Timber Pharmaceuticals’ Q1 2024 earnings at ($0.49) EPS, Q2 2024 earnings at ($0.42) EPS, Q3 […] ....